A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
Clinical trial NCT01878786 · TERMINATED
Trial details
- NCT number
- NCT01878786
- Sponsor
- Matthew Cooper
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.